🇺🇸 FDA
Patent

US 11446310

Stable formulations for parenteral injection of small molecule drugs

granted A61KA61K31/137A61K31/167

Quick answer

US patent 11446310 (Stable formulations for parenteral injection of small molecule drugs) held by XERIS PHARMACEUTICALS, INC. expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XERIS PHARMACEUTICALS, INC.
Grant date
Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/137, A61K31/167, A61K31/352, A61K31/4045